Provided by Tiger Fintech (Singapore) Pte. Ltd.

Kalvista Pharmaceuticals Inc

13.55
-0.0500-0.37%
Post-market: 13.550.00000.00%16:05 EDT
Volume:520.42K
Turnover:7.12M
Market Cap:673.65M
PE:-3.64
High:13.91
Open:13.66
Low:13.44
Close:13.60
Loading ...
Dec 30, 2021

Beneficial Ownership Change

SC 13D - General statement of acquisition of beneficial ownership
Dec 09, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Dec 09, 2021

Major Issues Report

8-K - Current report
Oct 25, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Oct 04, 2021

Major Issues Report

8-K - Current report
Sep 17, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Sep 15, 2021

Major Issues Report

8-K - Current report
Sep 09, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Sep 09, 2021

Major Issues Report

8-K - Current report
Jul 13, 2021

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Jul 13, 2021

Major Issues Report

8-K - Current report
Jul 13, 2021

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Jun 30, 2021

Major Issues Report

8-K - Current report
Jun 10, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jun 07, 2021

Major Issues Report

8-K - Current report
May 27, 2021

Correspondence

CORRESP [Cover] - Correspondence
May 27, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
May 07, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Mar 19, 2021

Major Issues Report

8-K - Current report
Mar 11, 2021

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans